FIN FINAL PROJECT.docx - FIN 254 Sec:12 Group Project on...

SchoolNorth South University
Course TitleFIN 254
Uploaded Byfahim518764
Pages39
Ratings 100% (2)

This preview shows page 1 - 4 out of 39 pages.

Group Project on Square and Beximco PharmaceuticalsPrepared ForNazmun NaharLecturer, NSU SBEPrepared ByNameIDFarhad Bin Alam1210739030Ahmed Iqraam1310338630Abdullah Al Yusuf1310471630MD. Abdul Kyoom Fahim1320098030Zulekram Elahe1320103030Rehnuma Binte Saif1330453630Table Of ContentsTopicPage NumberIntroductionPage 2Ratio AnalysisPage 3Ratio Analysis for SquarePage 4Ratio Analysis for BeximcoPage 5Liquidity RatiosPages 6 & 7 Activity RatiosPages 8, 9 & 10Profitability RatiosPages 11, 12, 13, 14, 15, 16 & 17Debt RatiosPages 18 & 19Market RatiosPages 20, 21 & 22FIN 254 Sec:12

32Cross Sectional Analysis of Square Pharmaceuticals (Table)Page 23Cross Sectional Analysis of Beximco Pharmaceuticals (Table)Page 24Cross Sectional Analysis of Square and Beximco Pharmaceuticals (Full Description)Pages 25, 26 & 27RecommendationsPage 28ConclusionPage 29Excel Sheets for Square PharmaceuticalsPages 30, 31 & 32 Excel Sheets for Beximco PharmaceuticalsPages 33, 34 & 35 Appendix for Square PharmaceuticalsPages 36, 37 & 38Appendix for Beximco PharmaceuticalsPages 39, 40 & 41ReferencesPage 42IntroductionSquare Pharmaceuticals:SQUARE today symbolizes a name – a state of mind. But its journey to the growth andprosperity has been no bed of roses. From the inception in 1958, it has today burgeoned intoone of the top line conglomerates in Bangladesh. Square Pharmaceuticals Ltd., the flagshipcompany, is holding the strong leadership position in the pharmaceutical industry ofBangladesh since 1985 and is now on its way to becoming a high performance global player.SQUARE Pharmaceuticals Limited is the largest pharmaceutical company in Bangladesh andit has been continuously in the 1st position among all national and multinational companiessince 1985. It was established in 1958 and converted into a public limited company in 1991.The sales turnover of SPL was more than Taka 11.46 Billion (US$ 163.71 million) with about16.43% market share (April 2009– March 2010) having a growth rate of about 16.72%.SQUARE Pharmaceuticals Limited has extended its range of services towards the highway ofglobal market. It pioneered exports of medicines from Bangladesh in 1987 and has beenexporting antibiotics and other pharmaceutical products. This extension in business andservices has manifested the credibility of Square Pharmaceuticals Limited.Beximco Pharmaceuticals

32Beximco Pharmaceuticals Ltd (Beximco Pharma) is an emerging generic drug playercommitted to providing access to affordable medicines. Company’s state-of-the-artmanufacturing facilities have been accredited by the regulatory authorities of USA, Australia,European Union, Canada, and Brazil, among others, and it currently focuses on buildingpresence in many emerging and developed markets around the world.Beximco Pharma is consistently building upon its portfolio and currently producing morethan 500 products encompassing broad therapeutic categories and the Company has createdstrong differentiation by offering a range of high-tech, specialized products which aredifficult to imitate.